Suzanne L. Bruhn's most recent trade in Vigil Neuroscience Inc was a trade of 33,875 Stock Option Award (Right to Buy) done . Disclosure was reported to the exchange on Aug. 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Aug 2025 | 33,875 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Aug 2025 | 24,310 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Aug 2025 | 24,073 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Aug 2025 | 18,068 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Aug 2025 | 13,928 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Aug 2025 | 6,235 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Aug 2025 | 5,000 | 0 | - | - | Common Stock | |
| Mind Medicine Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 75,187 | 75,187 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 30,000 | 30,000 | - | - | Common Stock (Right to Buy) | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 5,000 | 5,000 | - | 0 | Common Stock | |
| Travere Therapeutics Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 19,500 | 19,500 | - | - | Stock option (right to buy) | |
| Travere Therapeutics Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 6,500 | 28,750 (0%) | 0% | 0 | Common Stock | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 33,875 | 33,875 | - | - | Stock Option Award (Right to Buy) | |
| Pliant Therapeutics Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 26,764 | 26,764 | - | - | Common Stock (Right to Buy) | |
| Mind Medicine Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 16,506 | 16,506 | - | - | Stock Option (Right to Buy) | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 18,068 | 18,068 | - | - | Stock Option Award (Right to Buy) | |
| Travere Therapeutics Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 19,500 | 19,500 | - | - | Stock option (right to buy) | |
| Travere Therapeutics Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 6,500 | 22,250 (0%) | 0% | 0 | Common Stock | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 May 2024 | 24,310 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 24,310 | 24,310 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 May 2024 | 13,928 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 13,928 | 13,928 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 May 2024 | 6,235 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 6,235 | 6,235 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 24,073 | 24,073 | - | - | Stock Option Grant (Right to Buy) | |
| Pliant Therapeutics Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 14,000 | 14,000 | - | - | Stock Option (Right to Buy) | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 13,928 | 13,928 | - | - | Stock Option Grant (Right to Buy) | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 6,235 | 6,235 | - | - | Stock Option Grant (Right to Buy) | |
| Vigil Neuroscience Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2022 | 24,310 | 24,310 | - | - | Stock Option Grant (Right to Buy) | |
| Pliant Therapeutics Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Travere Therapeutics Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 9,000 | 9,000 | - | - | Stock option (right to buy) | |
| Travere Therapeutics Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 3,000 | 11,250 (0%) | 0% | 0 | Common Stock | |
| Avalo Therapeutics Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 5,204 | 5,204 | - | - | Stock Option (Right to Buy) | |
| Avalo Therapeutics Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 3,465 | 3,465 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 13,286 | 13,286 | - | - | Stock Option (right to buy) | |
| Avalo Therapeutics Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Travere Therapeutics Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 9,000 | 9,000 | - | - | Stock option (right to buy) | |
| Travere Therapeutics Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 3,000 | 8,250 (0%) | 0% | 0 | Common Stock | |
| Avalo Therapeutics Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 4,173 | 4,173 | - | - | Stock Option (Right to Buy) | |
| Avalo Therapeutics Inc | Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 4,325 | 4,325 | - | - | Stock Option (Right to Buy) |